Summary: To study the role of intestinal mast cells in Crohn's disease, a sensitive glass-fiber histamine assay was conducted in conjunction with mechanical dispersion of surgical specimens of 80 macroscopically actively inf lamed colons, 40 non-inflamed colons, 40 actively inflamed ileums, and 16 non-inflamed ileums from patients with Crohn's disease and 96 control subjects.
A strong correlation was found between the number of mast cells and the total histamine content in the controls (r= 0.682) (p<0.05). The number of mast cells was decreased in Crohn's disease as compared with the controls (p<0.01).
Intestinal mast cells release histamine in a dose-dependent manner after challenges with anti -IgE (1.875-240.0 U/ml).
A significant dif ference was noted in the release by anti-IgE between actively inflamed an non-inflamed colons of patients with Crohn's disease or control subjects (p< 0.01). Mast cells in actively inflamed tissue with Crohn's disease were shown to have different roles in the pathogenesis of inflammation.
Introduction Schwartz et al. (1983) and Spiegelberg (1984) There was a strong correlation between the number of mast cells and the total histamine content in the control group (r=0.682) (Fig. 2) . Assuming a tissue density of 1 mg/mm3, the histamine con- Fig. 2 . Correlation between total his tamine content and number of intestinal mast cells in control tissues from surgical specimens (r=0.682) (p<0.05). Fig. 3 . Total histamine content (ng/100 mg) of specimens from the colons in con trol subjects (n= 96) and from non-inflamed ileums (n=16), actively inflamed ileums (n=40), non-inflamed colons (n=40), and actively inflamed colons (n=80) in patients with Crohn's disease (N. C.). tent was found to be 44.8 pg/cell. No significant difference in total histamine content of actively inflamed tissue and either non-inflamed tissue with Crohn's disease or control tissue could be found (Fig. 3) or control tissues (p<0.01) (Fig. 5) . Otherwise, no significant differences in the rates of histamine release after chal lenges with anti-IgE from actively in flamed ileum, non-inflamed ileum in Crohn's disease and control tissues were found (Fig. 6 ).
Discussion
The early lesions of Crohn's disease, the study of which should provide insight into how the disease is initiated, have been examined by observing seemingly uninvolved areas of bowel wall adjacent to areas with frank disease.
Mast cells increase modestly in Crohn's disease, par ticularly in the submucosal area and around blood vessels (Dvorac et al. 1978) . However, mast cells may be increased (Hiatt et al. 1962 ), remain unchanged (Thompson et al. 1979 , or be decreased (Lloyd et al. 1975; Sanderson et al. 1986 ) in Crohn's disease. In this study, analysis of histological sections demonstrated that there is a significant decrease of intes tinal mast cells in actively inflamed tis sue with Crohn's disease. The reason for this discrepancy from previous reports may be due to difficulties in preserving mast cell structure during fixation of tis sues. Electron microscopic studies (Dvorac and Monahan, 1983) have indicated that mast cells in the active areas of Crohn's disease are degranulated, which may con tribute to an understanding of the mast cell density.
These cells undoubtedly f acilitate the influx of additional cellular elements into an already established le sion. Capron et al. (1986) Recently, glass-microf fibers have been found to bind histamine with high af finity and selectivity, and this method was used to study the histamine release by anti-IgE from mast cells obtained from surgical specimens in Crohn's disease that were dispersed mechanically (Skov et al. 1985) . The activation may be unique to Crohn's disease. In fact, mast cells would respond in an inflammatory role with the type of activation or hyperresponsiveness observed.
Histamine releasing activity appears to be produced by T lymphocytes and this production is stimulated by an tigens and T cell mitogens (Nable et al. 1981; Sedgwick et al. 1981; Shulman et al. 1985) . Intestinal mast cells need T cell factors (IL-3, IL-4) for maturation, but there also seems to be a more direct relationship between these cells in the induction of mediator release. It is es pecially interesting that the differences in mast cell responsiveness are seen after challenges with low doses of IgE in spite of in significant differences in the spon taneous release of histamine between in flamed tissues and either non-inflamed tissues with Crohn's disease or control tissues. This indicates that a lymphokine or other cytokine induces a substantial change in the signal transduction appa ratus. The increased levels of histamine could be explained by changes in the cy toskeleton that allow greater exocytosis of granules or changes in the granules themselves, further allowing greater lib eration of histamine from the proteoglycan matrix.
However 
